Skip to main content
ETST
OTC Life Sciences

ETST Reports Strong FY26 with $1.2M Share Buyback, Debt-Free Growth, and Cash Flow Positive Operations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.179
Mkt Cap
$52.16M
52W Low
$0.001
52W High
$0.237
52W Position
Off High info
24% below high
Rel. Volume
Market data snapshot near publication time

Summary

Earth Science Tech, Inc. released its annual shareholder letter for FY2026, highlighting over $1.2 million in share repurchases, significant debt-free operational growth, and cash flow positive performance across its health and wellness segment.


Key Events · Corporate Governance and Compliance · ETST

  • Significant Share Repurchases

    The company repurchased and retired over 6.9 million shares of common stock since Q1 FY2026, totaling approximately $1.24 million, representing 2.37% of its market capitalization.

  • Debt-Free Operational Growth

    Multiple acquisitions and new ventures, including Mister Meds, DOConsultation, Villas Health, and MyOnlineConsultation, were launched and expanded without incurring additional debt, and are now cash flow positive.

  • Strong Segment Performance

    Peaks Curative surpassed $2 million in revenue in the first week of Fiscal Q4 2026, contributing to the company's overall cash flow positive operating platform.

  • Positive Future Outlook

    Management expressed confidence in continued geographic expansion, potential acquisitions, and the Health/Wellness segment driving most of the revenue in the current fiscal year.


Analysis · ETST · Life Sciences

This 8-K provides a comprehensive positive update on Earth Science Tech's performance, emphasizing a substantial share repurchase program valued at over $1.2 million, representing 2.37% of the company's market capitalization. The letter details successful, debt-free expansion of its health and wellness operations, including acquisitions and new platform launches that are now cash flow positive. These achievements, coupled with a strong outlook and management's confidence, suggest improved financial health and a commitment to shareholder value.

At the time of this filing, ETST was trading at $0.18 on OTC in the Life Sciences sector, with a market capitalization of approximately $52.2M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ETST - Latest Insights

ETST
Jul 02, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.135
Real-time Price: $0.120 info
Change: -$0.015 (-11%) info
Market Cap: $34.511M info
ETST
Jun 18, 2026, 6:15 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.1799
Real-time Price: $0.120 info
Change: -$0.0599 (-33%) info
Market Cap: $34.511M info
ETST
Jun 18, 2026, 6:06 AM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $0.1799
Real-time Price: $0.120 info
Change: -$0.0599 (-33%) info
Market Cap: $34.511M info
ETST
Jun 10, 2026, 8:43 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.179
Real-time Price: $0.120 info
Change: -$0.059 (-33%) info
Market Cap: $34.511M info
ETST
Mar 24, 2026, 9:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.100
Real-time Price: $0.120 info
Change: +$0.020 (+20%) info
Market Cap: $34.511M info